Europe - Frankfurt Stock Exchange - FRA:ACT - DE000A2YNT30 - Common Stock
The current stock price of ACT.DE is 131.2 EUR. In the past month the price decreased by -15.97%. In the past year, price increased by 114.95%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1COV.DE | COVESTRO AG | N/A | 11.17B | ||
| SY1.DE | SYMRISE AG | 19.32 | 9.80B | ||
| AKZA.AS | AKZO NOBEL N.V. | 15.19 | 9.46B | ||
| AKU1.DE | AKZO NOBEL N.V. | 15.14 | 9.43B | ||
| SYENS.BR | SYENSQO SA | 21.21 | 7.16B | ||
| EVK.DE | EVONIK INDUSTRIES AG | 9.57 | 6.06B | ||
| AKE.PA | ARKEMA | 10.06 | 3.94B | ||
| UMI.BR | UMICORE | 13.95 | 3.88B | ||
| NVJP.DE | UMICORE | 13.56 | 3.77B | ||
| WCH.DE | WACKER CHEMIE AG | 151.51 | 3.40B | ||
| RBT.PA | ROBERTET SA | 18.85 | 1.92B | ||
| CRBN.AS | CORBION NV | 16.91 | 1.10B |
Alzchem Group AG engages in the provision of development, production, and marketing of chemical products. The company is headquartered in Trostberg, Bayern and currently employs 1,725 full-time employees. The Group's operating business is divided into three segments: Specialty Chemicals, Basics & Intermediates and Other & Holding. Its products can be applied in areas, such as nutrition, renewable energy, fine chemicals, agriculture and metallurgy. The firm produces dietary supplements; epoxy resin hardeners for use in adhesives, powder coatings, printed circuit boards and composites; silicon nitride for advanced ceramics and solar wafers; technical gases; specialty fertilizer, germicide for use in pig pens, plant growth regulators and plant protection additives, among others. The company also provides related services. The firm operates production sites in Germany and Sweden, a sales subsidiary in the United States and a Chinese subsidiary for the purchase of raw materials and distribution in Asia.
ALZCHEM GROUP AG
Chemiepark Trostberg, Dr.-Albert-Frank-Str. 32
Trostberg BAYERN DE
Employees: 1647
Phone: 498621860
Alzchem Group AG engages in the provision of development, production, and marketing of chemical products. The company is headquartered in Trostberg, Bayern and currently employs 1,725 full-time employees. The Group's operating business is divided into three segments: Specialty Chemicals, Basics & Intermediates and Other & Holding. Its products can be applied in areas, such as nutrition, renewable energy, fine chemicals, agriculture and metallurgy. The firm produces dietary supplements; epoxy resin hardeners for use in adhesives, powder coatings, printed circuit boards and composites; silicon nitride for advanced ceramics and solar wafers; technical gases; specialty fertilizer, germicide for use in pig pens, plant growth regulators and plant protection additives, among others. The company also provides related services. The firm operates production sites in Germany and Sweden, a sales subsidiary in the United States and a Chinese subsidiary for the purchase of raw materials and distribution in Asia.
The current stock price of ACT.DE is 131.2 EUR. The price increased by 1.39% in the last trading session.
ALZCHEM GROUP AG (ACT.DE) has a dividend yield of 1.37%. The yearly dividend amount is currently 1.2.
ACT.DE has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
ALZCHEM GROUP AG (ACT.DE) currently has 1647 employees.
ALZCHEM GROUP AG (ACT.DE) has a market capitalization of 1.34B EUR. This makes ACT.DE a Small Cap stock.
ChartMill assigns a technical rating of 4 / 10 to ACT.DE. When comparing the yearly performance of all stocks, ACT.DE is one of the better performing stocks in the market, outperforming 96.47% of all stocks.
ChartMill assigns a fundamental rating of 7 / 10 to ACT.DE. ACT.DE scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
Over the last trailing twelve months ACT.DE reported a non-GAAP Earnings per Share(EPS) of 6.1. The EPS increased by 24.12% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.97% | ||
| ROA | 10.49% | ||
| ROE | 26.47% | ||
| Debt/Equity | 0.16 |
11 analysts have analysed ACT.DE and the average price target is 157.34 EUR. This implies a price increase of 19.92% is expected in the next year compared to the current price of 131.2.
For the next year, analysts expect an EPS growth of 18.28% and a revenue growth 2.83% for ACT.DE